Scarica l'app Stockscreener
2.30
3.14%
0.07
Dopo l'orario di chiusura:
2.50
0.20
+8.70%
Alpha Tau Medical Ltd Borsa (DRTS) Ultime notizie
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Significant Growth in Short Interest - MarketBeat
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Grows By 30.5% - Defense World
Alpha Tau Medical to Showcase at Key Healthcare Conferences - TipRanks
Alpha Tau to Participate in Citi's 2024 Global Healthcare Conference and Piper Sandler's 36th Annual Healthcare Conference - The Manila Times
Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference - Marketscreener.com
Alpha Tau to Participate in Citi’s 2024 Global Healthcare - GlobeNewswire
Alpha Tau Medical to Hold Annual Shareholder Meeting - TipRanks
Alpha Tau Medical : Notice and proxy statement for the annual general meeting of shareholders of the Company to be held on December 17, 2024 Form 6 K - Marketscreener.com
Medical Lasers Market Growth and Technology 2024 - openPR
MasterCraft Boat Holdings, Inc. (NASDAQ:MCFT) Receives $19.20 Average Target Price from Analysts - Defense World
Spire Global, Inc. (NYSE:SPIR) Receives $13.67 Average Target Price from Brokerages - Defense World
Brinker International (NYSE:EAT) Sets New 52-Week High After Analyst Upgrade - Defense World
Invesco Solar ETF Target of Unusually High Options Trading (NYSEARCA:TAN) - Defense World
Traders Buy High Volume of Call Options on Nutrien (NYSE:NTR) - Defense World
Brokerages Set Silvaco Group, Inc. (NASDAQ:SVCO) PT at $20.83 - Defense World
Analysts Set Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) PT at $34.60 - Defense World
Orthofix Medical (NASDAQ:OFIX) and Alpha Tau Medical (NASDAQ:DRTS) Financial Contrast - Defense World
Top 230+ startups in Radiation Therapy Devices in Nov, 2024 - Tracxn
Comparing Alpha Tau Medical (NASDAQ:DRTS) and Beyond Air (NASDAQ:XAIR) - Defense World
Discover Alpha Tau Medical And 2 Other US Penny Stocks - Simply Wall St
Head-To-Head Review: Biotricity (NASDAQ:BTCY) vs. Alpha Tau Medical (NASDAQ:DRTS) - Defense World
HC Wainwright Reiterates "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Joins FDA Program to Advance Cancer Therapy - TipRanks
Alpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme - The Manila Times
Alpha Tau Announces Acceptance Into FDA’s Total Product - GlobeNewswire
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme - Yahoo Finance
Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Update - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Stock Rating Reaffirmed by HC Wainwright - Defense World
Alpha Tau Medical shares maintain Buy rating from H.C. Wainwright By Investing.com - Investing.com Canada
Alpha Tau’s Alpha DaRT Advances Lung Cancer Treatment - Yahoo Finance
HC Wainwright Reaffirms "Buy" Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat
Alpha Tau Medical shares maintain Buy rating from H.C. Wainwright - Investing.com
Alpha Emitter Market Size to witness nearly $1751.5 Million By 2032 - 대구포스트
Alpha Tau treats first lung cancer patient with radiation therapy in Jerusalem - Mugglehead
Alpha Tau Treats First Patient with Recurrent Lung Cancer - ForexTV.com
Alpha Tau Medical Ltd. Treats First Patient with Recurrent Lung Cancer - Marketscreener.com
Alpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer - Marketscreener.com
Radiopharmaceutical Market 2024 – Industry Opportunities, Challenges, Value Chain and Sales Channels Analysis 2032 | Clarity Pharmaceuticals - 대구포스트
Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Expands By 23.9% - MarketBeat
Alpha Emitter Market Outlook, Key Trends and Growth Projections from 2024 to 2032 - 대구포스트
Alpha Emitter Market on the Rise: A Study on its Growth Prospects - openPR
Point72 DIFC Ltd Acquires Shares of 18,774 ChampionX Co. (NASDAQ:CHX) - Defense World
Alpha Tau Medical Ltd.FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC - Marketscreener.com
FDA approves study of Alpha Tau’s Alpha DaRT for recurrent cSCC treatment - Yahoo Finance
Global Alpha Emitter Market Set to Reach $ 1751.5 Million by 2032, Expanding at 11.25% CAGR - 대구포스트
Alpha Tau’s Alpha DaRT Gains FDA Study Approval - TipRanks
Alpha Tau Medical Ltd. Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT in Immunocompromised Patients with Recurrent cSCC - Marketscreener.com
Alpha Tau Announces FDA Approval of IDE to Initiate - GlobeNewswire
Sidoti Events, LLC's Virtual September Small-Cap Conference - Yahoo Finance
Alpha Tau Medical Share PriceDRTS, RNS News, Articles, Quotes, & Charts (NASDAQ:DRTS) - Proactive Investors Australia
Alpha Tau Medical’s Alpha DaRT Technology Shows Breakthrough Results in Cancer Trials - Proactive Investors Australia
23,323 Shares in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Purchased by Caprock Group LLC - Defense World
Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 5.3% - Defense World
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 63.4% in August - MarketBeat
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):